Petros Pharmaceuticals, Inc. Quarterly Operating Margin in % from Q4 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Petros Pharmaceuticals, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2020 to Q3 2024.
  • Petros Pharmaceuticals, Inc. Operating Margin for the quarter ending September 30, 2024 was -338 %.
  • Petros Pharmaceuticals, Inc. annual Operating Margin for 2023 was -234 %, a 29.6% increase from 2022.
  • Petros Pharmaceuticals, Inc. annual Operating Margin for 2022 was -332 %, a 43.9% decline from 2021.
  • Petros Pharmaceuticals, Inc. annual Operating Margin for 2021 was -231 %, a 27.8% decline from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -338 Jul 1, 2024 Sep 30, 2024
Q2 2024 -390 Apr 1, 2024 Jun 30, 2024
Q1 2024 -346 Jan 1, 2024 Mar 31, 2024
Q4 2023 -234 Oct 1, 2023 Dec 31, 2023
Q2 2022 -173 -71.3 -70.2% Apr 1, 2022 Jun 30, 2022
Q1 2022 -263 -146 -125% Jan 1, 2022 Mar 31, 2022
Q4 2021 -231 -50.3 -27.8% Oct 1, 2021 Dec 31, 2021
Q3 2021 -124 Jul 1, 2021 Sep 30, 2021
Q2 2021 -102 Apr 1, 2021 Jun 30, 2021
Q1 2021 -117 Jan 1, 2021 Mar 31, 2021
Q4 2020 -181 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.